Full name
QPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
10.89.A - Production of dietary supplements
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.A - Production of dental devices, instruments, and products
46.38.Z - Wholesale trade of other food products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
70.10.B - Centralized shared services activities
70.20.Z - Business and management consultancy activities
73.12.Z - Advertising through mass media
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 3,2 | 5,6 | 7,4 | 32,8 |
Gross profit (loss) | 4,4 | 6 | 7,7 | 28,9 |
EBITDA | 4,3 | 5,8 | 7,4 | 28,3 |
Short time liabilities | 7,3 | 7,2 | 6,3 | -12,6 |
Other operating costs | 0,1 | 0,1 | 0,4 | 582,7 |
Equity capital | 18 | 19,3 | 21,7 | 12,9 |
Operating profit (EBIT) | 4,2 | 5,7 | 7,3 | 28,5 |
Assets | 25,7 | 26,7 | 28,6 | 6,8 |
Net profit (loss) | 3,8 | 4,9 | 6,2 | 26 |
Cash | 10,1 | 6 | 13 | 114,9 |
Net income from sale | 33,5 | 40,3 | 43,4 | 7,8 |
Liabilities and provisions for liabilities | 7,6 | 7,5 | 6,8 | -9,1 |
Working assets | 25,4 | 26,4 | 28,4 | 7,3 |
Other income costs | 1 | 0,1 | 0,2 | 90,7 |
Depreciation | 0,1 | 0,1 | 0,1 | 17,4 |
% | % | % | p.p. | |
Profitability of capital | 21 | 25,5 | 28,5 | 3 |
Equity capital to total assets | 70,3 | 72 | 76,2 | 4,2 |
Gross profit margin | 13,1 | 14,9 | 17,8 | 2,9 |
EBITDA Margin | 12,7 | 14,3 | 17 | 2,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 79 | 66 | 53 | -13 |
Current financial liquidity indicator | 3.482032537460327 | 3.655386209487915 | 4.490452766418457 | 0,8 |
Net dept to EBITDA | -2.1566388607025146 | -0.9877700209617615 | -1.7540522813796997 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane